Organ arrest, protection and preservation: natural hibernation to cardiac surgery
Dobson, Geoffrey P. (2004) Organ arrest, protection and preservation: natural hibernation to cardiac surgery. Comparative Biochemistry and Physiology-Part B: biochemistry & molecular biology, 139 (3). pp. 469-485.
|PDF (Published Version) - Repository staff only - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader|
View at Publisher Website: http://dx.doi.org/10.1016/j.cbpc.2004.06...
Cardiac surgery continues to be limited by an inability to achieve complete myocardial protection from ischemia-reperfusion injury. This paper considers the following questions: (1) what lessons can be learned from mammalian hibernators to improve current methods of human myocardial arrest, protection and preservation? and (2) can the human heart be pharmacologically manipulated during acute global ischemia to act more like the heart of a hibernating mammal? After reviewing the major entropy-slowing strategies of hibernation, a major player identified in the armortarium is maintenance of the membrane potential. The resting membrane potential of the hibernator's heart appears to be maintained close to its pre-torpid state of around −85 mV. In open-heart surgery, 99% of all surgical heart arrest solutions (cardioplegia) employ high potassium (>16 mM) which depolarises the membrane voltage from −85 to around −50 mV. However, depolarising potassium cardioplegia has been increasingly linked to myocyte and microvascular damage leading to functional loss during reperfusion. Our recent work has been borrowed from hibernation biology and is focused on a very different arrest strategy which ‘clamps’ the membrane near its resting potential and depresses O2 consumption from baseline by about 90%. The new ‘polarising’ cardioplegia incorporates adenosine and lidocaine (AL) as the arresting combination, not high potassium. Studies in the isolated rat heart show that AL cardioplegia delivered at 37 °C can arrest the heart for up to 4 h with 70–80% recovery of the cardiac output, 85–100% recovery of heart rate, systolic pressure and rate-pressure product and 70–80% of baseline coronary flows. Only 14% of hearts arrested with crystalloid St. Thomas' solution No. 2 cardioplegia survived after 4 h. In conclusion, maintenance of the myocardial membrane potential near or close to its resting state appears to be an important feature of the hibernator's heart that may find great utility in surgical arrest and cellular preservation strategies. Identifying and safely turning ‘off’ and ‘on’ the entropy-slowing genes to down-regulate the hibernator's heart and applying this to human organs and tissues remains a major challenge for future genomics and proteomics.
|Item Type:||Article (Refereed Research - C1)|
|Keywords:||adenosine; cardioplegia; heart; hibernating myocardium; hibernation; lidocaine; opiods; organ preservation; torpor; xenotransplantation|
|FoR Codes:||11 MEDICAL AND HEALTH SCIENCES > 1102 Cardiovascular Medicine and Haematology > 110201 Cardiology (incl Cardiovascular Diseases) @ 100%|
|SEO Codes:||92 HEALTH > 9201 Clinical Health (Organs, Diseases and Abnormal Conditions) > 920103 Cardiovascular System and Diseases @ 100%|
|Deposited On:||08 Jan 2010 09:42|
|Last Modified:||14 May 2013 00:50|
Last 12 Months: 0
|Citation Counts with External Providers:||Web of Science: 28|
Repository Staff Only: item control page